SOAT1 and type 2 diabetes mellitus: PCs may prevent apoptosis and alleviate neurological impairment in type 2 diabetes (T2D) model Sprague−Dawley rats with focal cerebral ischemia by decreasing STAT1 expression and inhibiting JAK/STAT signaling [103].